These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 15726379

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning.
    Simon GH, Bauer J, Saborovski O, Fu Y, Corot C, Wendland MF, Daldrup-Link HE.
    Eur Radiol; 2006 Mar; 16(3):738-45. PubMed ID: 16308692
    [Abstract] [Full Text] [Related]

  • 4. Ferumoxtran-10 enhancement in orthotopic xenograft models of human brain tumors: an indirect marker of tumor proliferation?
    Kremer S, Pinel S, Védrine PO, Bressenot A, Robert P, Bracard S, Plénat F.
    J Neurooncol; 2007 Jun; 83(2):111-9. PubMed ID: 17443290
    [Abstract] [Full Text] [Related]

  • 5. USPIO (Ferumoxtran-10)-enhanced MRI to visualize reticuloendothelial system cells in neonatal rats: feasibility and biodistribution study.
    Azoulay R, Olivier P, Baud O, Verney C, Santus R, Robert P, Gressens P, Sebag G.
    J Magn Reson Imaging; 2008 Oct; 28(4):1046-52. PubMed ID: 18821607
    [Abstract] [Full Text] [Related]

  • 6. MRI detection of macrophages labeled using micrometer-sized iron oxide particles.
    Williams JB, Ye Q, Hitchens TK, Kaufman CL, Ho C.
    J Magn Reson Imaging; 2007 Jun; 25(6):1210-8. PubMed ID: 17520727
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The pharmacokinetics of the lymphotropic nanoparticle MRI contrast agent ferumoxtran-10.
    Islam T, Wolf G.
    Cancer Biomark; 2009 Jun; 5(2):69-73. PubMed ID: 19414923
    [Abstract] [Full Text] [Related]

  • 9. Splenic imaging with ultrasmall superparamagnetic iron oxide ferumoxtran-10 (AMI-7227): preliminary observations.
    Harisinghani MG, Saini S, Weissleder R, Rubin D, deLange E, Harms S, Weinreb J, Small W, Sukerkar A, Brown JJ, Zelch J, Lucas M, Morris M, Hahn PF.
    J Comput Assist Tomogr; 2001 Jun; 25(5):770-6. PubMed ID: 11584239
    [Abstract] [Full Text] [Related]

  • 10. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
    Li X, Du X, Huo T, Liu X, Zhang S, Yuan F.
    Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Magnetic resonance imaging of liver metastases: experimental comparison of anionic and conventional superparamagnetic iron oxide particles with a hepatobiliary contrast medium during dynamic and uptake phases.
    Kaufels N, Korn R, Wagner S, Schink T, Hamm B, Taupitz M, Schnorr J.
    Invest Radiol; 2008 Jul; 43(7):496-503. PubMed ID: 18580332
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours.
    Neuwelt EA, Várallyay P, Bagó AG, Muldoon LL, Nesbit G, Nixon R.
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):456-71. PubMed ID: 15488022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.